Lee, W., Moon, J., Jang, Y., Shin, Y., Son, H., Shin, S., . . . Chu, K. (2024). Nilotinib treatment outcomes in autosomal dominant spinocerebellar ataxia over one year. Scientific Reports, 14(1), . https://doi.org/10.1038/s41598-024-67072-z
Chicago-referens (17:e uppl.)Lee, Woo-Jin, et al. "Nilotinib Treatment Outcomes in Autosomal Dominant Spinocerebellar Ataxia over One Year." Scientific Reports 14, no. 1 (2024). https://doi.org/10.1038/s41598-024-67072-z.
MLA-referens (9:e uppl.)Lee, Woo-Jin, et al. "Nilotinib Treatment Outcomes in Autosomal Dominant Spinocerebellar Ataxia over One Year." Scientific Reports, vol. 14, no. 1, 2024, https://doi.org/10.1038/s41598-024-67072-z.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.